ClinicalTrials.gov
ClinicalTrials.gov Menu

Nintedanib (BIBF 1120) in Mesothelioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01907100
Recruitment Status : Active, not recruiting
First Posted : July 24, 2013
Last Update Posted : July 6, 2018
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : March 16, 2018
  Estimated Study Completion Date : August 17, 2018